Asiacell and Evam Partner to Elevate Real-Time Customer Engagement Across Iraq’s Digital Landscape
DOHA, Qatar, Nov. 26, 2025 /PRNewswire/ — Asiacell, Iraq’s leading telecommunications and digital services provider, has entered into a strategic... Read more.
Hisense Showcases Next-Generation Smart Home Solutions at the Middle East Consumer Electronics Show 2025
DUBAI, UAE, Nov. 26, 2025 /PRNewswire/ — Hisense, a global leader in smart technology and home appliances, is showcasing its latest innovations at the Middle... Read more.
Nuvalent to Participate in the Piper Sandler 37th Annual Healthcare Conference
CAMBRIDGE, Mass., Nov. 26, 2025 /PRNewswire/ — Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted... Read more.
Immunic to Participate in the 8th Annual Evercore ISI Healthcare Conference in December
NEW YORK, Nov. 26, 2025 /PRNewswire/ — Immunic, Inc. (Nasdaq: IMUX), a late-stage biotechnology company pioneering the development of novel oral... Read more.
Subtle Medical Doubles Growth; Showcases New Releases and Strengthened Partnerships at RSNA 2025
Subtle’s Latest Solutions Set New Benchmarks for AI-powered Acceleration, Image Quality, and Organization MENLO PARK, Calif., Nov. 26, 2025 /PRNewswire/ —... Read more.
GRNBIT Cayman Holdings launch GrnBit Bitcoin Mining Fund
GEORGE TOWN, Cayman Islands, Nov. 26, 2025 /PRNewswire/ — CV5 Capital and GRNBIT (Cayman) Holdings today announced the launch of the GrnBit Sustainability... Read more.
Maison Law Unveils Groundbreaking Study on Pedestrian Safety in U.S. Cities
VISALIA, Calif., Nov. 26, 2025 /PRNewswire/ — Maison Law is proud to announce the release of a comprehensive new study examining pedestrian accident rates,... Read more.
Happiest Minds’ Integrated Annual Report 2025 wins double Gold, ranks #56 globally at LACP Spotlight Awards
BENGALURU, India and SEATTLE and LONDON, Nov. 26, 2025 /PRNewswire/ — Happiest Minds Technologies Limited (NSE: HAPPSTMNDS),... Read more.
Lighthouse Pharmaceuticals To Present Phase 2 SPRING Trial of LHP588, a Next-Generation Gingipain Inhibitor for the Treatment of P. gingivalis-Positive Alzheimer’s Disease, at CTAD 2025
NOVATO, Calif., Nov. 26, 2025 /PRNewswire/ — Lighthouse Pharmaceuticals, Inc. a clinical-stage biopharmaceutical company pioneering precision medicine... Read more.
AIRS Medical to Debut AI-Powered Brain Health Quantification and Reporting Solution SwiftSight™-Brain at RSNA 2025
CHICAGO, Nov. 26, 2025 /PRNewswire/ — AIRS Medical, a leader in AI-powered healthcare solutions, will unveil SwiftSight, a breakthrough brain health quantification... Read more.